House Bill 1000, titled the “Detransitioners Bill of Rights,” would create a new Article 1N in Chapter 90 of the North Carolina General Statutes governing gender transition procedures on minors and detransition-related care. The bill makes it unlawful for a medical professional to perform detransition procedures or surgical gender transition procedures on minors, or to prescribe, provide, or dispense puberty-blocking drugs or cross-sex hormones to minors, while allowing certain procedures with parental or guardian informed consent. It also defines a set of terms related to sex, gender, detransitioners, gender clinics, and detransition procedures, and establishes a framework for reporting, enforcement, and civil liability.
The bill would impose significant penalties on providers and entities that violate its restrictions. A medical professional who violates the article would face license revocation for at least one year, and an employing or contracting entity could be subject to a civil penalty of up to $250,000. The bill also creates strict civil liability for harms allegedly caused by prohibited gender transition treatment of minors, and it authorizes lawsuits for detransition procedures, including damages, attorneys’ fees, and costs. It further requires gender clinics to report detailed patient and treatment data to the Department of Health and Human Services, and directs the Department to publish an annual statistical report.
HB1000 would also affect health insurance and vital records law. It would require health benefit plans that cover gender transition procedures for minors to also cover adverse consequences, monitoring, and treatment needed to manage, reverse, or recover from prior gender transition procedures, while stating that insurers are not required to cover gender transition procedures at all. In addition, the bill would allow a person who has detransitioned to request a change to the sex designation on a birth certificate with a physician’s notarized certification, and it would require insurers to report claims data related to gender transition and detransition procedures.
The bill’s sentiment, based on its text and the absence of recorded committee debate or votes in the provided materials, appears strongly supportive of restrictions on pediatric gender-affirming care and strongly protective of detransitioners and parental rights. The measure is framed as a rights-and-transparency bill for detransitioners, with provisions aimed at disclosure, insurance coverage, and legal remedies. Because no transcripts or votes are provided, there is no documented bipartisan or committee-level sentiment to assess beyond the bill’s own policy direction.
The main points of contention are likely to be the ban on medical treatment for minors, the scope of parental consent and access to records, the mandatory reporting of sensitive patient information, and the civil and professional penalties imposed on providers and employers. Opponents would likely focus on patient privacy, medical autonomy, and the impact on access to gender-affirming care, while supporters would emphasize detransitioner protections, parental authority, and oversight of gender clinics. The bill also appears to preempt local governments from restricting certain mental health services related to gender identity, which could raise additional state-local authority questions.
HB1000 would substantially amend Chapters 90, 58, and 130A of the North Carolina General Statutes by creating new rules for medical treatment of minors related to gender transition and detransition, insurance coverage for related care, and birth certificate amendments for detransitioners. It would impose new professional discipline, civil liability, reporting, and enforcement obligations on medical professionals, gender clinics, insurers, and the Department of Health and Human Services, while also limiting local government authority over certain mental health services and parental consent issues.
No committee transcript or vote record is provided, so there is no formal recorded legislative debate to summarize. Based on the bill text alone, the measure reflects a strongly pro-restriction and pro-detransitioner policy stance, with an emphasis on parental rights, transparency, and legal accountability for providers. The bill’s framing suggests support among sponsors for limiting pediatric gender-transition interventions and expanding remedies for detransition-related harms.
Likely areas of contention include the prohibition on puberty blockers, cross-sex hormones, and surgical gender transition procedures for minors; the bill’s strict liability and license-revocation provisions for providers; the extensive reporting requirements for gender clinics; and the requirement that insurers cover detransition-related care if they cover transition-related care. Privacy concerns may also arise from the mandated collection of patient age, sex, county of residence, diagnoses, and treatment details. Supporters are likely to prioritize detransitioner protections and parental rights, while opponents are likely to object to restrictions on gender-affirming care, state intrusion into medical decision-making, and the potential chilling effect on providers.